Foy M, Yip R, Chen X, Kimmel M, Gorlova OY, Henschke CI. Modeling the Mortality Reduction Due to Computed Tomography Screening for Lung Cancer. Cancer doi: 10.1002/cncr.25847.
Questions were raised by a reader about the financial disclosures provided by some of the authors of the above paper. The published disclosures were as follows:
“Drs. Foy, Gorlova, Kimmel, and Henschke were supported in part by the National Cancer Institute (NCI) Cancer Intervention and Surveillance Modeling Network (CISNET) grant U01CA097431. Dr. Gorlova was supported in part by a Prevent Cancer Foundation grant. Dr. Foy was supported in part by an NCI Cancer Prevention Fellowship (R25 CA57780, Principal Investigator: R. Chamberlain).”
In response to the specific concerns raised by the reader, the journal followed up with the authors and asked if there were any additional disclosures that should have been included prior to publication and whether any of the funding for the paper came from the American Cancer Society or tobacco companies.
The authors responded with the following information:
“No funds from the Foundation for Lung Cancer: Early Detection, Prevention and Treatment or from the American Cancer Society grant received in 2003 to 2007 were used in the data gathering, research, or writing of the paper “Modeling the mortality reduction due to computed tomography screening for lung cancer.” The data gathering of the screenings was supported by grants from the National Institutes of Health R01-CA-63393, R01-CA-78905, The City of New York, Department of Health and Mental Hygiene, New York State Office of Science, Technology and Academic Research (NYSTAR), General Electric, Kodak, Empire Blue Cross and Blue Shield, The Starr Foundation, Ernest E. Stempel Foundation, The New York Community Trust, The Rogers Family Fund, and AMDeC Foundation, Inc., none of which received any funding from tobacco companies or foundations.”
These additional disclosures should have been submitted previously by the authors in order to ensure full transparency in peer review and publication.
The editors of the journal have reviewed all of the information and determined that although the additional financial disclosures should have been disclosed previously, they would not have altered the decision to accept the paper.